Obermatt
See Similar Stocks →

Flags

Financial distress

National Research

NSQ:NRC · US6373722023
Health Care Providers & ServicesSmall

360

43
Medium confidence — indicative
Profit price13
Owner Earnings Yield56
Dividend Yield1
Price/Sales47
EV / Gross Profit36
Price/Book3
Return on Capital98
Cash Return on Capital65
Return on Equity98
EBIT Margin94
Gross Profitability89
Cash Conversion64
Accruals53
Owner Earnings Margin67
Sales growth38
Profit Growth21
Long-Term EPS Growth10
Owner Earnings Growth19
Reinvestment27
Price momentum65
Debt load9
Refinancing24
Debt Payback18
Liquidity62
Analyst ratings—
Expectations trend—
Market mood7
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

National Research clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Providers & Services
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Employees444
Websitenrchealth.com
ISINUS6373722023
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Corporate Wellness ProgramsConsumer ResearchPredictive AnalyticsCustomer AnalyticsArtificial IntelligenceAnalyticsHealth CareMedical

Description

NRC Health is a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience, while also increasing patient engagement and customer loyalty for healthcare organizations in the United St…

Analysis

Quality compounder

NRC Health earns the quality_compounder label: good underlying economics priced fairly, with no obvious bargain or excess. Worth noting: the cash the business generates has lagged behind what the income statement shows.

On valuation, the picture is expensive. The owner-earnings multiple stands at 54.6×; owner earnings: the cash an owner could take out each year.

Growth is tepid; the safety picture is stretched. The company scores 12/20 on our value-creation score: creating some value. Analysts lean positive.

Flags to be aware of: A large part of the company's book value is the price paid for past acquisitions. Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
1
20232026

All-time high

60

Jan 2023

All-time low

1

Jun 2026

Average rank

22

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
47
—
—
2
Price/Earnings
37
—
—
50
Price/Book
3
—
—
2
Dividend Yield
1
—
—
85
Value (overall)
8
—
—
41

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare National Research with its peers
LifeStance Health
NSQ:LFST
80
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Myriad Genetics
NSQ:MYGN
12
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Satellogic
NAQ:SATL
10
CountryUSA
IndustryAerospace & Defense
SizeSmall
Full Stock Analysis →
The Trade Desk
NMQ:TTD
89
CountryUSA
IndustryMedia
SizeLarge
Full Stock Analysis →
TripAdvisor
NSQ:TRIP
29
CountryUSA
IndustryInteractive Media & Services
SizeLarge
Full Stock Analysis →
Telesat
NSQ:TSAT
2
CountryCanada
IndustryDiversified Telecommunication Services
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →